Log in or Sign up for Free to view tailored content for your specialty!
Allergy/Asthma News
Asthma, metabolic syndrome worsen COVID-19 outcomes
Asthma increased the need for respiratory support in COVID-19 patients, whereas metabolic syndrome raised the risk for severe COVID-19, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Q&A: Company seeks to expand neffy FDA approval to more pediatric patients
ARS Pharmaceuticals announced its submission of a supplemental new drug application to the FDA for neffy 1 mg for the treatment of type 1 allergic reactions in children who weigh between 33 lb and 66 lb.
Log in or Sign up for Free to view tailored content for your specialty!
Text message reminders improve inhaler adherence in asthma, COPD
Adults with asthma and/or COPD who received 23 text messages about preventer inhaler use over 26 weeks had improved inhaler adherence, according to a poster presented at the European Respiratory Society International Congress.
Study: First-generation antihistamines may increase seizure risk in young children
A Korean study identified a 22% increased risk for seizure among young children who were prescribed first-generation antihistamines, according to findings published in JAMA Network Open.
Inflammation, mucus plugging improve by 4 weeks with dupilumab
Patients with asthma on dupilumab saw reduced airway inflammation and mucus plugging beginning at 4 weeks with steady improvements through 24 weeks, according to a study presented at the European Respiratory Society International Congress.
Patients with asthma, obesity experience improved control with GLP-1 RAs
Patients with asthma who used a glucagon-like peptide 1 receptor agonist for weight loss experienced improved asthma control, according to a poster presented at the European Respiratory Society International Congress.
Start early to leverage the power of compound interest
Saving money at an early age is perhaps the simplest and one of the most effective methods to accumulate wealth.
Spontaneous chronic urticaria improvement seen with Dupixent treatment
Patients with chronic spontaneous urticaria experienced a marked improvement with Dupixent treatment, according to phase 3 trial results released by Regeneron.
Depemokimab reduces severe asthma exacerbations by half with twice-yearly treatment
Patients with severe eosinophilic asthma who used depemokimab administered every 6 months experienced a 54% reduction in exacerbations over 52 weeks, according to a study presented at the European Respiratory Society International Congress.
Response to biologics for asthma varies by outcome
Patients with greater impairment before initiating biologic treatment for asthma had better response across all assessed outcomes, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read